| pubmed-article:6164738 | pubmed:abstractText | Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may even provide antibodies that can be used safely in vivo. | lld:pubmed |
